Repligen | RGEN - القيمة السوقية





القيمة السوقية تغيير تاريخ
Agilent USD 39.08B 6.43B 2026-06
Align Technology USD 12.08B 198M 2026-06
BioMarin Pharmaceutical USD 11.06B 196M 2026-06
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Bruker USD 9.16B 3.66B 2026-06
Charles River Laboratories USD 10.39B 2.54B 2026-06
Danaher USD 138.86B 10.4B 2026-06
Dentsply International USD 2.13B 191M 2026-06
General Electric Aerospace USD 389.93B 93.44B 2026-06
Henry Schein USD 9.68B 1.4B 2026-06
Illumina USD 26.71B 8.84B 2026-06
IQVIA Holdings USD 32.25B 3.62B 2026-06
Mettler Toledo International USD 25.82B 278M 2026-06
OraSure Technologies USD 174M 61M 2025-12
Pacific Biosciences Of California USD 565M 180M 2025-12
Pfizer USD 138.44B 15.37B 2026-06
Repligen USD 7.7B 1.05B 2026-06
Revvity USD 12.69B 2.75B 2026-06
Standard Biotools USD 359M 133M 2026-03
Thermo Fisher Scientific USD 190.65B 7.99B 2026-06
Waters USD 37.24B 7.38B 2026-06
West Pharmaceutical Services USD 25.36B 7.3B 2026-06